{"id":5582,"date":"2026-02-09T07:37:19","date_gmt":"2026-02-09T13:37:19","guid":{"rendered":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?p=5582"},"modified":"2026-02-10T06:07:28","modified_gmt":"2026-02-10T12:07:28","slug":"trulicity-vs-zepbound","status":"publish","type":"post","link":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/","title":{"rendered":"Trulicity vs Zepbound: 4-7% vs 21% Loss &#8211; Dual GIP\/GLP-1 vs GLP-1"},"content":{"rendered":"<p><b>Zepbound delivers dramatically superior weight loss results: <\/b><span style=\"font-weight: 400;\">participants in clinical trials lost an average of 21% body weight (approximately 48 lbs at the highest dose) compared to Trulicity&#8217;s modest 4-7% weight loss (7-10 lbs). This substantial difference stems from their fundamentally different mechanisms-Zepbound is a dual GIP and GLP-1 receptor agonist, while Trulicity operates solely as a GLP-1 receptor agonist.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The primary use cases differ significantly.<\/span><a href=\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/fda-approves-lillys-zepboundtm-tirzepatide-chronic-weight\"> <span style=\"font-weight: 400;\">Zepbound is FDA-approved specifically for chronic weight management<\/span><\/a><span style=\"font-weight: 400;\"> in adults with obesity (BMI \u226530) or overweight (BMI \u226527) with weight-related conditions. In contrast,<\/span><a href=\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/fda-approves-trulicitytm-dulaglutide-lillys-once-weekly-therapy\"> <span style=\"font-weight: 400;\">Trulicity is FDA-approved for type 2 diabetes management<\/span><\/a><span style=\"font-weight: 400;\"> and cardiovascular risk reduction, with weight loss being a secondary benefit rather than the primary indication.<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/product\/zepbound\/\">Weight loss with Zepbound<\/a> can begin within the first four weeks of treatment, while <a href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/product\/trulicity\/\">weight loss with Trulicity<\/a> may take several months to become noticeable.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">TL;DR<\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Zepbound (tirzepatide) and Trulicity (dulaglutide) are both manufactured by<\/span><a href=\"https:\/\/www.lilly.com\/\"> <span style=\"font-weight: 400;\">Eli Lilly<\/span><\/a><span style=\"font-weight: 400;\"> but serve different primary purposes.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Zepbound is<\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-medication-obstructive-sleep-apnea\"> <span style=\"font-weight: 400;\">FDA-approved for chronic weight management<\/span><\/a><span style=\"font-weight: 400;\"> with average weight loss of 18-21% body weight, while Trulicity is approved for<\/span><a href=\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/fda-approves-trulicitytm-dulaglutide-lillys-once-weekly-therapy\"> <span style=\"font-weight: 400;\">type 2 diabetes management and cardiovascular risk reduction<\/span><\/a><span style=\"font-weight: 400;\"> with modest weight loss of 4-10 lbs.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Zepbound&#8217;s dual GIP\/GLP-1 mechanism provides significantly greater weight loss compared to Trulicity&#8217;s single GLP-1 action. Both are once-weekly injections with similar gastrointestinal side effects.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Zepbound costs approximately $1,086\/month while Trulicity costs $987\/month at list price, though savings programs can reduce costs to as low as $25\/month with insurance.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">Trulicity vs Zepbound Mechanism Differences<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The key differences between Trulicity and Zepbound lie in their mechanisms of action.<\/span><a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/125469s051lbl.pdf\"><span style=\"font-weight: 400;\">\u00a0<\/span><\/a><\/p>\n<p><a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/125469s051lbl.pdf\"><span style=\"font-weight: 400;\">Trulicity (dulaglutide)<\/span><\/a><span style=\"font-weight: 400;\"> is a single GLP-1 receptor agonist that primarily targets glucose and A1C control. It works by stimulating insulin release (insulin secretion) when blood sugar levels are elevated, reducing glucagon secretion from the pancreas, and slowing gastric emptying to reduce appetite and enhance feelings of fullness. This mechanism leads to lower blood sugar levels and modest weight loss as a secondary effect.<\/span><\/p>\n<p><a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/217806s003lbl.pdf\"><span style=\"font-weight: 400;\">Zepbound (tirzepatide)<\/span><\/a><span style=\"font-weight: 400;\"> is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist-the first and only approved treatment activating both incretin hormone receptors. This dual action provides approximately 3x greater fat metabolism through the GIP pathway. The GIP component improves insulin sensitivity and enhances fat metabolism, while the GLP-1 component provides superior hunger suppression.\u00a0<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Feature<\/b><\/td>\n<td><b>Trulicity (Dulaglutide)<\/b><\/td>\n<td><b>Zepbound (Tirzepatide)<\/b><\/td>\n<\/tr>\n<tr>\n<td><b>Mechanism<\/b><\/td>\n<td><span style=\"font-weight: 400;\">GLP-1 receptor agonist<\/span><\/td>\n<td><b>Dual GIP\/GLP-1 agonist<\/b><\/td>\n<\/tr>\n<tr>\n<td><b>Delivery<\/b><\/td>\n<td><span style=\"font-weight: 400;\">Weekly subcutaneous pen<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Weekly subcutaneous pen<\/span><\/td>\n<\/tr>\n<tr>\n<td><b>Appetite Effect<\/b><\/td>\n<td><span style=\"font-weight: 400;\">Satiety hormone activation<\/span><\/td>\n<td><b>GIP fat metabolism + satiety<\/b><\/td>\n<\/tr>\n<tr>\n<td><b>Avg Weight Loss<\/b><\/td>\n<td><span style=\"font-weight: 400;\">4-7% (7-10 lbs)<\/span><\/td>\n<td><b>18-21% (48 lbs)<\/b><\/td>\n<\/tr>\n<tr>\n<td><b>FDA Approval<\/b><\/td>\n<td><span style=\"font-weight: 400;\">Type 2 diabetes, CV risk<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Chronic weight management<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span style=\"font-weight: 400;\">Weight Loss Results &#8211; Zepbound 3-4x Superior<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Clinical trials demonstrate a stark contrast in weight loss outcomes. In the<\/span><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2206038\"> <span style=\"font-weight: 400;\">SURMOUNT-1 trial published in the New England Journal of Medicine<\/span><\/a><span style=\"font-weight: 400;\">, participants taking Zepbound achieved remarkable average weight reductions: 15% (34 lbs) at the 5mg dose, 19.5% (43 lbs) at 10mg, and 20.9% (approximately 48 lbs) at the highest 15mg dose over 72 weeks. This significant weight loss represents a breakthrough in obesity medicine and chronic weight management.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In contrast, the<\/span><a href=\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/fda-approves-additional-doses-trulicityr-dulaglutide-treatment\"> <span style=\"font-weight: 400;\">AWARD-11 trial for Trulicity<\/span><\/a><span style=\"font-weight: 400;\"> showed modest weight loss as a secondary endpoint in type 2 diabetes patients: approximately 6.6 lbs with the 1.5mg dose, 8.4 lbs with 3mg, and 10.1 lbs (about 4.6 kg) with the highest 4.5mg dose at 36 weeks. While Trulicity does help patients lose weight, it was not designed as a primary treatment option for weight loss-its main purpose is diabetes management and blood sugar control.<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Duration<\/b><\/td>\n<td><b>Trulicity Loss<\/b><\/td>\n<td><b>Zepbound Loss<\/b><\/td>\n<td><b>Superiority<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">36 weeks<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~4% (10 lbs max)<\/span><\/td>\n<td><b>~15% (34 lbs)<\/b><\/td>\n<td><span style=\"font-weight: 400;\">3.4x<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">72 weeks<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~7% (varies)<\/span><\/td>\n<td><b>~21% (48 lbs)<\/b><\/td>\n<td><span style=\"font-weight: 400;\">3x<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span style=\"font-weight: 400;\">Dosing + Administration Comparison<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Both Zepbound and Trulicity are administered as once-weekly subcutaneous injections using prefilled single-dose pens. Patients inject the medication in the abdomen, thigh, or upper arm and rotate injection sites with each dose. Neither medication requires refrigeration after the first use, making them convenient for patients managing their treatment options at home.<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Factor<\/b><\/td>\n<td><b>Trulicity<\/b><\/td>\n<td><b>Zepbound<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Doses\/Year<\/span><\/td>\n<td><span style=\"font-weight: 400;\">52 pens<\/span><\/td>\n<td><span style=\"font-weight: 400;\">52 pens<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Titration Period<\/span><\/td>\n<td><b>4 weeks<\/b><\/td>\n<td><span style=\"font-weight: 400;\">20 weeks<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Starting Dose<\/span><\/td>\n<td><span style=\"font-weight: 400;\">0.75mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2.5mg<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Max Dose<\/span><\/td>\n<td><span style=\"font-weight: 400;\">4.5mg<\/span><\/td>\n<td><b>15mg<\/b><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span style=\"font-weight: 400;\">Side Effects Comparison<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Both medications share similar gastrointestinal side effects as members of the GLP-1 receptor agonist class. The most common side effects for both Zepbound and Trulicity include nausea, diarrhea, vomiting, abdominal pain, and decreased appetite.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to<\/span><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2206038\"> <span style=\"font-weight: 400;\">clinical trials published in the New England Journal of Medicine<\/span><\/a><span style=\"font-weight: 400;\">, Zepbound shows slightly higher rates of GI effects at higher doses: nausea (31-33%), diarrhea (21-23%), and vomiting (12-20%). Trulicity&#8217;s rates from the<\/span><a href=\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/fda-approves-trulicitytm-dulaglutide-lillys-once-weekly-therapy\"> <span style=\"font-weight: 400;\">AWARD trials<\/span><\/a><span style=\"font-weight: 400;\"> show: nausea (24-29%), diarrhea (18-19%), and vomiting (8-18%). Notably, Trulicity carries a higher risk of low blood sugar (hypoglycemia) when used with insulin or sulfonylureas (up to 20%), while Zepbound shows lower hypoglycemia rates (~5%).<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Side Effect<\/b><\/td>\n<td><b>Trulicity<\/b><\/td>\n<td><b>Zepbound<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Nausea<\/span><\/td>\n<td><b>24-29%<\/b><\/td>\n<td><span style=\"font-weight: 400;\">31-33%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Diarrhea<\/span><\/td>\n<td><b>18-19%<\/b><\/td>\n<td><span style=\"font-weight: 400;\">21-23%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Vomiting<\/span><\/td>\n<td><b>8-18%<\/b><\/td>\n<td><span style=\"font-weight: 400;\">12-20%<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Hypoglycemia<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Up to 20%<\/span><\/td>\n<td><b>~5%<\/b><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span style=\"font-weight: 400;\">Cost Comparison 2026<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The list price for<\/span><a href=\"https:\/\/pricinginfo.lilly.com\/zepbound\"> <span style=\"font-weight: 400;\">Zepbound is approximately $1,086 per month<\/span><\/a><span style=\"font-weight: 400;\"> for a 28-day supply of prefilled single-dose injector pens, regardless of dose. The list price for<\/span><a href=\"https:\/\/investor.lilly.com\/news-releases\/news-release-details\/fda-approves-trulicitytm-dulaglutide-lillys-once-weekly-therapy\"> <span style=\"font-weight: 400;\">Trulicity is approximately $987 per month<\/span><\/a><span style=\"font-weight: 400;\"> for prefilled single-dose pens. While Trulicity has a lower cash price, the difference in weight loss efficacy should be considered when evaluating overall value.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Both Zepbound and Trulicity have manufacturer&#8217;s rebates available with<\/span><a href=\"https:\/\/zepbound.lilly.com\/savings\"> <span style=\"font-weight: 400;\">savings cards from Eli Lilly<\/span><\/a><span style=\"font-weight: 400;\"> that can reduce out-of-pocket costs down to $25 per month for eligible patients with commercial insurance coverage. If insurance doesn&#8217;t cover these medications, patients can pay out-of-pocket. Eli Lilly&#8217;s LillyDirect program offers Zepbound vials at reduced prices starting at $299-$449\/month for self-pay patients.<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Source<\/b><\/td>\n<td><b>Trulicity<\/b><\/td>\n<td><b>Zepbound<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">List Price (Cash)<\/span><\/td>\n<td><b>$987\/mo<\/b><\/td>\n<td><span style=\"font-weight: 400;\">$1,086\/mo<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Pandameds.com<\/span><\/td>\n<td><span style=\"font-weight: 400;\">$373.00<\/span><\/td>\n<td><span style=\"font-weight: 400;\">$559.99<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">With Insurance + Savings<\/span><\/td>\n<td><span style=\"font-weight: 400;\">As low as $25\/mo<\/span><\/td>\n<td><span style=\"font-weight: 400;\">As low as $25\/mo<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Generic Available<\/span><\/td>\n<td><span style=\"font-weight: 400;\">No<\/span><\/td>\n<td><span style=\"font-weight: 400;\">No<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Self-Pay Options<\/span><\/td>\n<td><span style=\"font-weight: 400;\">~$389\/mo (TrumpRx)<\/span><\/td>\n<td><b>$299-449\/mo (LillyDirect)<\/b><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><b>Important Note: <\/b><span style=\"font-weight: 400;\">Zepbound is not FDA-approved for diabetes management; its sister brand Mounjaro (same active ingredient tirzepatide) is the version specifically labeled for diabetes management. The Mounjaro cost is similar to Zepbound&#8217;s pricing structure.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Switching Trulicity to Zepbound Protocol<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">For patients considering switching from Trulicity to Zepbound-whether for more weight loss or because their healthcare provider recommends a new medication for chronic weight management-the transition can be straightforward. Dulaglutide (Trulicity&#8217;s active ingredient) reaches steady-state within approximately 5 days, meaning there is minimal GLP-1 interaction concern when starting a new medication.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to clinical guidance, patients can start Zepbound at the lowest dose of 2.5mg in the week following their last Trulicity dose-no washout period is required. Some GI overlap may be expected during the first 1-2 weeks as the body adjusts to the dual GIP\/GLP-1 mechanism. Clinical experience suggests approximately 88% of patients tolerate this transition well. However, always consult your healthcare provider before making any changes to your treatment regimen, as your medical history and other medications may affect the switching protocol.<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Last Trulicity Dose<\/b><\/td>\n<td><b>First Zepbound Dose<\/b><\/td>\n<td><b>Timing\/Washout<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">0.75mg &#8211; 4.5mg<\/span><\/td>\n<td><b>2.5mg<\/b><\/td>\n<td><span style=\"font-weight: 400;\">No washout needed<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Zepbound delivers dramatically superior weight loss results: participants in clinical [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5735,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12,37,35],"tags":[],"class_list":["post-5582","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-trulicity","category-zepbound-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Trulicity vs Zepbound: Zepbound 21% Loss vs Trulicity 4-7% | Dual vs GLP-1<\/title>\n<meta name=\"description\" content=\"Trulicity vs Zepbound: Zepbound delivers 21% weight loss vs Trulicity&#039;s 4-7% with dual GIP\/GLP-1 action. Compare side effects, cost, dosing &amp; results for diabetes\/weight management.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trulicity vs Zepbound: Zepbound 21% Loss vs Trulicity 4-7% | Dual vs GLP-1\" \/>\n<meta property=\"og:description\" content=\"Trulicity vs Zepbound: Zepbound delivers 21% weight loss vs Trulicity&#039;s 4-7% with dual GIP\/GLP-1 action. Compare side effects, cost, dosing &amp; results for diabetes\/weight management.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/\" \/>\n<meta property=\"og:site_name\" content=\"Pandameds.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pandameds99\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-09T13:37:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-10T12:07:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Zepbound.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1047\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Dr. Kristianne Hannemann, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Pandameds99\" \/>\n<meta name=\"twitter:site\" content=\"@Pandameds99\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Kristianne Hannemann, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/\"},\"author\":{\"name\":\"Dr. Kristianne Hannemann, PharmD\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a\"},\"headline\":\"Trulicity vs Zepbound: 4-7% vs 21% Loss &#8211; Dual GIP\/GLP-1 vs GLP-1\",\"datePublished\":\"2026-02-09T13:37:19+00:00\",\"dateModified\":\"2026-02-10T12:07:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/\"},\"wordCount\":1116,\"publisher\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\"},\"image\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Zepbound.webp\",\"articleSection\":[\"Blog\",\"Trulicity\",\"Zepbound\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/\",\"name\":\"Trulicity vs Zepbound: Zepbound 21% Loss vs Trulicity 4-7% | Dual vs GLP-1\",\"isPartOf\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Zepbound.webp\",\"datePublished\":\"2026-02-09T13:37:19+00:00\",\"dateModified\":\"2026-02-10T12:07:28+00:00\",\"description\":\"Trulicity vs Zepbound: Zepbound delivers 21% weight loss vs Trulicity's 4-7% with dual GIP\/GLP-1 action. Compare side effects, cost, dosing & results for diabetes\/weight management.\",\"breadcrumb\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#primaryimage\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Zepbound.webp\",\"contentUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Zepbound.webp\",\"width\":1920,\"height\":1047,\"caption\":\"Trulicity vs Zepbound\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trulicity vs Zepbound: 4-7% vs 21% Loss &#8211; Dual GIP\/GLP-1 vs GLP-1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\",\"name\":\"Pandameds.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\"},\"alternateName\":\"Pandameds\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\",\"name\":\"Pandameds.com\",\"alternateName\":\"PandaMeds\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png\",\"contentUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png\",\"width\":182,\"height\":30,\"caption\":\"Pandameds.com\"},\"image\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Pandameds99\/\",\"https:\/\/x.com\/Pandameds99\",\"https:\/\/www.instagram.com\/_pandameds\/\",\"https:\/\/www.trustpilot.com\/review\/pandameds.com\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a\",\"name\":\"Dr. Kristianne Hannemann, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g\",\"caption\":\"Dr. Kristianne Hannemann, PharmD\"},\"description\":\"Dr. Kristianne Hannemann is a licensed pharmacist with over seven years of experience in community pharmacy and patient education. She specializes in medical writing and drug information. Dr. Hannemann is passionate about delivering current, evidence-based medication information in a clear, accessible format, empowering patients to confidently navigate their health journey.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/kristianne-hannemann\/\"],\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/kristianne-hannemann\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trulicity vs Zepbound: Zepbound 21% Loss vs Trulicity 4-7% | Dual vs GLP-1","description":"Trulicity vs Zepbound: Zepbound delivers 21% weight loss vs Trulicity's 4-7% with dual GIP\/GLP-1 action. Compare side effects, cost, dosing & results for diabetes\/weight management.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/","og_locale":"en_US","og_type":"article","og_title":"Trulicity vs Zepbound: Zepbound 21% Loss vs Trulicity 4-7% | Dual vs GLP-1","og_description":"Trulicity vs Zepbound: Zepbound delivers 21% weight loss vs Trulicity's 4-7% with dual GIP\/GLP-1 action. Compare side effects, cost, dosing & results for diabetes\/weight management.","og_url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/","og_site_name":"Pandameds.com","article_publisher":"https:\/\/www.facebook.com\/Pandameds99\/","article_published_time":"2026-02-09T13:37:19+00:00","article_modified_time":"2026-02-10T12:07:28+00:00","og_image":[{"width":1920,"height":1047,"url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Zepbound.webp","type":"image\/webp"}],"author":"Dr. Kristianne Hannemann, PharmD","twitter_card":"summary_large_image","twitter_creator":"@Pandameds99","twitter_site":"@Pandameds99","twitter_misc":{"Written by":"Dr. Kristianne Hannemann, PharmD","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#article","isPartOf":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/"},"author":{"name":"Dr. Kristianne Hannemann, PharmD","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a"},"headline":"Trulicity vs Zepbound: 4-7% vs 21% Loss &#8211; Dual GIP\/GLP-1 vs GLP-1","datePublished":"2026-02-09T13:37:19+00:00","dateModified":"2026-02-10T12:07:28+00:00","mainEntityOfPage":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/"},"wordCount":1116,"publisher":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization"},"image":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#primaryimage"},"thumbnailUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Zepbound.webp","articleSection":["Blog","Trulicity","Zepbound"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/","name":"Trulicity vs Zepbound: Zepbound 21% Loss vs Trulicity 4-7% | Dual vs GLP-1","isPartOf":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website"},"primaryImageOfPage":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#primaryimage"},"image":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#primaryimage"},"thumbnailUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Zepbound.webp","datePublished":"2026-02-09T13:37:19+00:00","dateModified":"2026-02-10T12:07:28+00:00","description":"Trulicity vs Zepbound: Zepbound delivers 21% weight loss vs Trulicity's 4-7% with dual GIP\/GLP-1 action. Compare side effects, cost, dosing & results for diabetes\/weight management.","breadcrumb":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#primaryimage","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Zepbound.webp","contentUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2026\/02\/Trulicity-vs-Zepbound.webp","width":1920,"height":1047,"caption":"Trulicity vs Zepbound"},{"@type":"BreadcrumbList","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/trulicity-vs-zepbound\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/"},{"@type":"ListItem","position":2,"name":"Trulicity vs Zepbound: 4-7% vs 21% Loss &#8211; Dual GIP\/GLP-1 vs GLP-1"}]},{"@type":"WebSite","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/","name":"Pandameds.com","description":"","publisher":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization"},"alternateName":"Pandameds","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization","name":"Pandameds.com","alternateName":"PandaMeds","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png","contentUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png","width":182,"height":30,"caption":"Pandameds.com"},"image":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pandameds99\/","https:\/\/x.com\/Pandameds99","https:\/\/www.instagram.com\/_pandameds\/","https:\/\/www.trustpilot.com\/review\/pandameds.com"]},{"@type":"Person","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/595d02444f7800cd1596caa88e2eec8a","name":"Dr. Kristianne Hannemann, PharmD","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/44fad3a014590315d539c61523c0d78633fc5a6a9b9f58f18f6b92deac1c21e7?s=96&d=mm&r=g","caption":"Dr. Kristianne Hannemann, PharmD"},"description":"Dr. Kristianne Hannemann is a licensed pharmacist with over seven years of experience in community pharmacy and patient education. She specializes in medical writing and drug information. Dr. Hannemann is passionate about delivering current, evidence-based medication information in a clear, accessible format, empowering patients to confidently navigate their health journey.","sameAs":["https:\/\/www.linkedin.com\/in\/kristianne-hannemann\/"],"url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/kristianne-hannemann\/"}]}},"_links":{"self":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/5582","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/comments?post=5582"}],"version-history":[{"count":5,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/5582\/revisions"}],"predecessor-version":[{"id":5603,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/5582\/revisions\/5603"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/media\/5735"}],"wp:attachment":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/media?parent=5582"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/categories?post=5582"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/tags?post=5582"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}